Skip to main content

Silk Road Medical Inc

SILKDelisted Sep 17, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001397702

Silk Road Medical Inc was delisted on Sep 17, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 172 institutions reported holding it in 13F filings for Q2 2024, worth $1.03B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Silk Road Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Silk Road Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Silk Road Medical Inc
NameTitleLast reported holdingLast filingFilings, past year
Lasersohn Jack WDirector0Sep 18, 20240
Weatherman Elizabeth HDirector0Sep 18, 20240
Zurbay DonaldDirector0Sep 18, 20240
Klemz Kevin MEVP/Chief Legal Officer/Sec.0Sep 18, 20240
Anderson Rick DDirector0Sep 18, 20240
Ballinger Kevin J.Director0Sep 18, 20240
McKhann ChasChief Executive Officer0Sep 18, 20240
Buchanan Lucas W.COO & CFO0IndirectSep 18, 20240
Chou Tony M.Director0Sep 18, 20240
Davis Andrew S.Chief Commercial Officer0Sep 18, 20240
Ruedy RichardEVPClin&Reg.Affairs&QA0IndirectSep 18, 20240
Carino TanishaDirector0Sep 18, 20240
Jones Marie L.VP, Finance and CAO0Sep 18, 20240
Rogers Erica J.President and CEO267,988Sep 29, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 6, 2023 (view filing)Mar 33 daysBuchanan Lucas W.COO/CFOSSale−9.92K$47.11−$467.2K−4.6%205.6K after
Mar 6, 2023 (view filing)Mar 6Same dayDavis Andrew S.Chief Commercial OfficerSSale−3.87K$47.74−$184.7K−3.2%115.7K after
Mar 6, 2023 (view filing)Mar 6Same dayRuedy RichardEVPClin&Reg.Affairs&QASSale−2.37K$47.73−$113.3K−1.6%145.5K after
Mar 15, 2023 (view filing)Mar 132 daysRogers Erica J.President and CEOSSale−6.00K$42.23−$253.4K−2.2%269.1K after
Mar 17, 2023 (view filing)Mar 152 daysWeatherman Elizabeth HDirectorSSale−5.00K$41.91−$209.6K−3.2%149.5K after
Apr 5, 2023 (view filing)Apr 32 daysDavis Andrew S.Chief Commercial OfficerSSale−6.75K$39.42−$266.2K−5.5%115.7K after3 lots
Apr 12, 2023 (view filing)Apr 111 dayRogers Erica J.President and CEOSSale−6.00K$39.77−$238.6K−2.2%269.1K after
Apr 19, 2023 (view filing)Apr 172 daysWeatherman Elizabeth HDirectorSSale−5.00K$41.91−$209.6K−3.3%144.5K after
May 3, 2023 (view filing)May 12 daysDavis Andrew S.Chief Commercial OfficerSSale−6.75K$44.51−$300.6K−5.5%115.7K after4 lots
May 12, 2023 (view filing)May 111 dayRogers Erica J.President and CEOSSale−3.00K$35.51−$106.5K−1.1%269.1K after2 lots
Jun 13, 2023 (view filing)Jun 121 dayRogers Erica J.President and CEOSSale−1.00K$32.13−$32.1K−0.4%269.6K after
Jul 10, 2023 (view filing)Jul 64 daysDavis Andrew S.Chief Commercial OfficerSSale−69$30.79−$2.12K−0.1%115.6K after
Jul 13, 2023 (view filing)Jul 112 daysRogers Erica J.President and CEOSSale−1.00K$31.56−$31.6K−0.4%269.6K after
Aug 4, 2023 (view filing)Aug 31 dayDavis Andrew S.Chief Commercial OfficerSSale−6.59K$22.13−$145.8K−5.7%109.5K after
Aug 18, 2023 (view filing)Aug 171 dayKlemz Kevin MEVP/Chief Legal Officer/Sec.SSale−1.54K$20.11−$30.9K−3.8%38.8K after
Sep 29, 2023 (view filing)Mar 2, 2021941 daysLateRogers Erica J.President and CEOSSale−1.65K$56.62−$93.5K−0.6%268.0K after
Oct 6, 2023 (view filing)Oct 42 daysBuchanan Lucas W.COO/CFOSSale−2.66K$15.22−$40.5K−0.6%435.8K after
Oct 30, 2023 (view filing)Oct 273 daysJones Marie L.CAO and VP, FinanceSSale−656$6.61−$4.34K−1.2%54.9K after
Mar 4, 2024 (view filing)Feb 294 daysRuedy RichardEVPClin&Reg.Affairs&QASSale−3.00K$22.25−$66.8K−1.7%170.8K after10b5-1
Mar 5, 2024 (view filing)Mar 5Same dayKlemz Kevin MEVP/Chief Legal Officer/Sec.SSale−2.50K$17.17−$42.9K−1.5%165.2K after
Mar 5, 2024 (view filing)Mar 5Same dayJones Marie L.VP, Finance and CAOSSale−2.60K$17.17−$44.7K−3.3%76.9K after
Mar 5, 2024 (view filing)Mar 5Same dayDavis Andrew S.Chief Commercial OfficerSSale−5.48K$17.17−$94.1K−1.9%287.8K after
Mar 5, 2024 (view filing)Mar 5Same dayRuedy RichardEVPClin&Reg.Affairs&QASSale−3.80K$17.17−$65.2K−1.8%205.7K after
Mar 5, 2024 (view filing)Mar 5Same dayBuchanan Lucas W.COO/CFOSSale−9.88K$17.17−$169.6K−1.9%500.9K after
Mar 7, 2024 (view filing)Mar 52 daysBallinger Kevin J.DirectorPPurchase+11.7K$16.99+$198.8K+191.6%17.8K after
Jul 8, 2024 (view filing)Jul 35 daysDavis Andrew S.Chief Commercial OfficerSSale−66$27.00−$1.78K0.0%289.7K after
Aug 21, 2024 (view filing)Aug 192 daysKlemz Kevin MEVP/Chief Legal Officer/Sec.SSale−2.27K$27.10−$61.5K−1.4%162.9K after